AIAXIO-AI Matched To Your Need

15,370 AI tools for 3,204 Tasks

Rejuve logo

Rejuve

1.0.0

4

0

Longevity Measuring
Track your longevity, improve your health, and get rewarded.
Input:
Output:
Rejuve screenshot
Updated: Mar 5, 2022 Free

Description

Rejuve is a decentralized, AI-driven network dedicated to advancing longevity research by uniting researchers, clinics, and data contributors.

Participants have the opportunity to earn from their health data while playing a part in significant breakthroughs related to aging. By enabling members to earn RJV tokens, which can be used for discounts on supplements, medical evaluations, treatments, and more, the network makes longevity therapies more accessible and cost-effective.

The Rejuve Longevity App assists users in monitoring and enhancing their lifespan and overall health. The network leverages diverse AI technologies, notably the OpenCog Hyperon AGI engine, an open-source platform designed to foster the development of Artificial General Intelligence (AGI).

Their Bayesian Expert probabilistic logic Bayesian net service simplifies the creation of Bayesian networks from medical literature, based on expert insights and statistical data.

Furthermore, their Generative Cooperative Network (GCN) is a deep neural embedding framework that integrates various neural architectures to produce embedding vectors representing aspects of each member's profile.

Rejuve collaborates with numerous entities, including SingularityNET Foundation, Cryptopia Group, and Tru Diagnostic. The network is also guided by a team of experts, including Jasmine Smith as CEO, Dr.

Deborah Duong as CTO, and Dr. Ben Goertzel as Chief AI Scientist.

Pricing Plans

Model
free
Packages
1 Package
Price Start From
free
Payment Model
Not specified

Releases

First release of Rejuve.

Reviews

Pros & Cons

Pros

Decentralized network structure

Advances longevity research efforts

Option to monetize health-related data

Cons

Requires knowledge of blockchain technology

Reliance on RJV tokens

Potential data privacy considerations

Q&A

New Released

New Released